BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [PMID: 31314133 DOI: 10.1002/hep.30866] [Cited by in Crossref: 262] [Cited by in F6Publishing: 209] [Article Influence: 87.3] [Reference Citation Analysis]
Number Citing Articles
1 Ye S, Chen B, Liu X, Zhang Z, Zhao W, Wang H, Ren L, Zhao B, Zhou Q, Chen X, Yang Y, Cao P, Ye J. Wangshi Baochi Pills alleviate alcoholic liver disease by regulating the gut microbiota composition in a mouse model. Pharmacological Research - Modern Chinese Medicine 2023;6:100208. [DOI: 10.1016/j.prmcm.2022.100208] [Reference Citation Analysis]
2 Alexandre W, Muhammad H, Agbalajobi O, Zhang G, Gmelin T, Adejumo A, Noll A, Jonassaint NL, DiMartini A, Bataller R, Rogal SS. Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis. BMC Gastroenterol 2023;23:29. [PMID: 36732709 DOI: 10.1186/s12876-023-02656-z] [Reference Citation Analysis]
3 Patel PV, Flamm SL. Alcohol-Related Liver Disease Including New Developments. Clin Liver Dis 2023;27:157-72. [PMID: 36400463 DOI: 10.1016/j.cld.2022.08.005] [Reference Citation Analysis]
4 Eguchi A, Iwasa M, Nakagawa H. Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets. Liver Int 2023;43:292-8. [PMID: 36462157 DOI: 10.1111/liv.15490] [Reference Citation Analysis]
5 Sundar V, Saraswathi V. Effect of Ethanol on Exosome Biogenesis: Possible Mechanisms and Therapeutic Implications. Biomolecules 2023;13:222. [DOI: 10.3390/biom13020222] [Reference Citation Analysis]
6 Leal C, Strogoff-de-Matos J, Theodoro C, Teixeira R, Perez R, Guaraná T, de Tarso Pinto P, Guimarães T, Artimos S. Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals. Viruses 2023;15. [PMID: 36680260 DOI: 10.3390/v15010221] [Reference Citation Analysis]
7 Chen PH, Sung HC, Punchhi G, Krach M, Greenberg R, Gianaris K, Teles M, Kaplow K, Wheatley J, Cameron AM, Chander G. Patient reflections, challenges, and supports related to early liver transplant for severe alcohol-associated liver disease. Liver Transpl 2023. [PMID: 36728621 DOI: 10.1097/LVT.0000000000000059] [Reference Citation Analysis]
8 Wu J, Kim A, Wu X, Ray S, Allende DS, Welch N, Bellar A, Dasarathy J, Dasarathy S, Nagy LE. 5S rRNA pseudogene transcripts are associated with interferon production and inflammatory responses in alcohol-associated hepatitis. Hepatology 2023. [PMID: 36645226 DOI: 10.1097/HEP.0000000000000024] [Reference Citation Analysis]
9 Im GY. Emerging Biomarkers in Alcohol-associated Hepatitis. J Clin Exp Hepatol 2023;13:103-15. [PMID: 36647419 DOI: 10.1016/j.jceh.2022.07.246] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Goodheart RH, Ayonrinde OT. Depiction of alcohol-related liver disease in the EASL International Liver Congress. J Hepatol 2023;78:e36-8. [PMID: 35988684 DOI: 10.1016/j.jhep.2022.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol 2023;20:37-49. [PMID: 36258033 DOI: 10.1038/s41575-022-00688-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Parker R. Reply. Clin Gastroenterol Hepatol 2023;21:237. [PMID: 35378293 DOI: 10.1016/j.cgh.2022.03.029] [Reference Citation Analysis]
13 Kivimäki M, Bartolomucci A, Kawachi I. The multiple roles of life stress in metabolic disorders. Nat Rev Endocrinol 2023;19:10-27. [PMID: 36224493 DOI: 10.1038/s41574-022-00746-8] [Reference Citation Analysis]
14 Ntandja Wandji LC, Ningarhari M, Lassailly G, Dharancy S, Boleslawski E, Mathurin P, Louvet A. Liver Transplantation in Alcohol-related Liver Disease and Alcohol-related Hepatitis. J Clin Exp Hepatol 2023;13:127-38. [PMID: 36647412 DOI: 10.1016/j.jceh.2022.06.013] [Reference Citation Analysis]
15 Gómez-Medina C, Melo L, Martí-Aguado D, Bataller R. Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection. Clin Mol Hepatol 2023;29:1-15. [PMID: 35430784 DOI: 10.3350/cmh.2022.0017] [Reference Citation Analysis]
16 Åberg F, Byrne CD, Pirola CJ, Männistö V, Sookoian S. Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease. J Hepatol 2023;78:191-206. [PMID: 36063967 DOI: 10.1016/j.jhep.2022.08.030] [Reference Citation Analysis]
17 P M, R SKJ, N P, J U SK, R S, N D S, R R, C IM, H M K. Artabotrys odoratissimus Bark Extract Restores Ethanol Induced Redox Imbalance and Toxicity in Hepatocytes and In Vivo Model. Appl Biochem Biotechnol 2022. [PMID: 36585550 DOI: 10.1007/s12010-022-04275-y] [Reference Citation Analysis]
18 Durkin C, Bittermann T. Liver transplantation for alcohol-associated hepatitis. Curr Opin Organ Transplant 2022. [PMID: 36512482 DOI: 10.1097/MOT.0000000000001044] [Reference Citation Analysis]
19 Thakral N, Deutsch-Link S, Singal AK. Therapeutic Pipeline in Alcohol-Associated Liver Disease. Semin Liver Dis 2022. [PMID: 36572032 DOI: 10.1055/s-0042-1759614] [Reference Citation Analysis]
20 Ionele CM, Turcu-Stiolica A, Subtirelu MS, Ungureanu BS, Sas TN, Rogoveanu I. Osteoporosis Assessment among Adults with Liver Cirrhosis. J Clin Med 2022;12. [PMID: 36614954 DOI: 10.3390/jcm12010153] [Reference Citation Analysis]
21 Vélez Aguirre JD, Yepez Barreto IDJ. Factores asociados a la masa y la fuerza muscular en pacientes con cirrosis hepática: un estudio transversal. Rev colomb Gastroenterol 2022;37:410-419. [DOI: 10.22516/25007440.936] [Reference Citation Analysis]
22 Malnick SDH, Alin P, Somin M, Neuman MG. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. Int J Mol Sci 2022;23. [PMID: 36555867 DOI: 10.3390/ijms232416226] [Reference Citation Analysis]
23 Pimienta M, Tien C, Terrault NA. Prospective clinical trials and novel therapies in the medical management of severe alcohol-associated hepatitis. Clin Liver Dis (Hoboken) 2022;20:202-8. [PMID: 36523864 DOI: 10.1002/cld.1265] [Reference Citation Analysis]
24 Lan Y, Chen W, Yen C, Chong K, Chen Y, Fan H, Chen M, Chen C. Aldo-Keto Reductase Family 1 Member A1 (AKR1A1) Deficiency Exacerbates Alcohol-Induced Hepatic Oxidative Stress, Inflammation, Steatosis, and Fibrosis.. [DOI: 10.1101/2022.12.07.519420] [Reference Citation Analysis]
25 Archanioti P, Dufour J. Liver tests: what to measure and what to do when abnormal. Schweiz Gastroenterol 2022. [DOI: 10.1007/s43472-022-00085-z] [Reference Citation Analysis]
26 Zhang Y, Miao X, Liu F, Shi H, Chen D, Ma Y, Shi H. ASPP2 deficiency attenuates lipid accumulation through the PPARγ pathway in alcoholic liver injury.. [DOI: 10.21203/rs.3.rs-2311513/v1] [Reference Citation Analysis]
27 Johnson E, Ghosh M, Daniels VJ, Wild TC, Campbell-scherer D, Mellinger J, Winder GS, Fernandez AC, Kirkwood J, Tandon P. The development and evaluation of a provider-focused educational intervention about alcohol use disorder in patients with cirrhosis. Canadian Liver Journal 2022. [DOI: 10.3138/canlivj-2022-0036] [Reference Citation Analysis]
28 Yamashiki N, Kawabata K, Murata M, Ikeda S, Fujimaki T, Suwa K, Seki T, Aramaki E, Naganuma M. Narrowing the patient–specialist gap: Pilot study of a diary smartphone-app for patients with alcohol-related liver disease (Preprint).. [DOI: 10.2196/preprints.44762] [Reference Citation Analysis]
29 Winder GS, Clifton EG, Perumalswami P, Mellinger JL. The art of interprofessional psychosocial communication: Optimizing patient interfaces with psychiatric specialists in liver transplantation. Transplantation Reviews 2022;36:100728. [DOI: 10.1016/j.trre.2022.100728] [Reference Citation Analysis]
30 Winder GS, Clifton EG, Mellinger JL. Substance use disorders in organ transplantation: perennial challenges and interprofessional opportunities. Curr Opin Organ Transplant 2022;27:495-500. [PMID: 36170560 DOI: 10.1097/MOT.0000000000001026] [Reference Citation Analysis]
31 Sinn DH, Kang D, Kang M, Guallar E, Hong YS, Lee KH, Park J, Cho J, Gwak GY. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study. Hepatology 2022;76:1746-54. [PMID: 35588190 DOI: 10.1002/hep.32578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
32 Weinberg EM, Dukewich M, Jakhete N, Stonesifer E, Im GY, Lucey MR, Shetty K, Rice JP, Victor DW 3rd, Ghobrial MR, Shetty A, Rutledge SM, Florman SS, Hsu C, Shoreibah M, Aryan M, Orandi BJ, Han H, Terrault N, Lee BP. Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation. Am J Gastroenterol 2022;117:1990-8. [PMID: 35853462 DOI: 10.14309/ajg.0000000000001901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kulle A, Thanabalasuriar A, Cohen TS, Szydlowska M. Resident macrophages of the lung and liver: The guardians of our tissues. Front Immunol 2022;13:1029085. [PMID: 36532044 DOI: 10.3389/fimmu.2022.1029085] [Reference Citation Analysis]
34 Schulz P, Shabbir R, Ramakrishnan S, Asrani SK. Acute Alcohol-Associated Hepatitis in the COVID-19 Pandemic — a Structured Review. Curr Transpl Rep 2022. [DOI: 10.1007/s40472-022-00387-w] [Reference Citation Analysis]
35 Gripshover TC, Wahlang B, Head KZ, Young JL, Luo J, Mustafa MT, Kirpich IA, Cave MC. The environmental pollutant, polychlorinated biphenyl 126, alters liver function in a rodent model of alcohol-associated liver disease. Alcohol Clin Exp Res 2022. [PMID: 36377258 DOI: 10.1111/acer.14976] [Reference Citation Analysis]
36 Wei M, Li T, Cao H, He H, Yang C, Yin Y, Lu H, Novák P, Zhang K, Gao Y. The effects of scoparone on alcohol and high-fat diet-induced liver injury revealed by RNA sequencing. Biomedicine & Pharmacotherapy 2022;155:113770. [DOI: 10.1016/j.biopha.2022.113770] [Reference Citation Analysis]
37 Ayyala D, Bottyan T, Tien C, Pimienta M, Yoo J, Stager K, Gonzalez JL, Stolz A, Dodge JL, Terrault NA, Han H. Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease. Hepatol Commun 2022;6:3433-42. [PMID: 36281979 DOI: 10.1002/hep4.2080] [Reference Citation Analysis]
38 Jairaman C, Alehaideb ZI, Yacoob SAM, Alghamdi SS, Suliman RS, Venkataraman A, Alghanem B, Sivanesan S, Vijayaraghavan R, Rameshbabu S, Pari SM, Matou-nasri S. Rhizophora mucronata Lam. (Mangrove) Bark Extract Reduces Ethanol-Induced Liver Cell Death and Oxidative Stress in Swiss Albino Mice: In Vivo and In Silico Studies. Metabolites 2022;12:1021. [DOI: 10.3390/metabo12111021] [Reference Citation Analysis]
39 No JS, Buckholz A, Han C, Matthews S, Fortune B, Krisko T, Newberry C, Kumar S. Identifying High-Risk Patients With Nonalcoholic Fatty Liver Disease: An Opportunity for Intervention Within the Primary Care Setting. J Clin Gastroenterol 2022. [PMID: 36731002 DOI: 10.1097/MCG.0000000000001784] [Reference Citation Analysis]
40 Wolstenholme JT, Saunders JM, Smith M, Kang JD, Hylemon PB, González-Maeso J, Fagan A, Zhao D, Sikaroodi M, Herzog J, Shamsaddini A, Peña-Rodríguez M, Su L, Tai YL, Zheng J, Cheng PC, Sartor RB, Gillevet PM, Zhou H, Bajaj JS. Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice. Nat Commun 2022;13:6198. [PMID: 36261423 DOI: 10.1038/s41467-022-34054-6] [Reference Citation Analysis]
41 Chen L, Lv X, Kan M, Wang R, Wang H, Zang H. Critical Overview of Hepatic Factors That Link Non-Alcoholic Fatty Liver Disease and Acute Kidney Injury: Physiology and Therapeutic Implications. IJMS 2022;23:12464. [DOI: 10.3390/ijms232012464] [Reference Citation Analysis]
42 Tayek JA, Stolz AA, Nguyen DV, Fleischman MW, Donovan JA, Alcorn JM, Chao DC, Asghar A, Morgan TR; Southern California Alcoholic Hepatitis (SCAH) Consortium. A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-associated hepatitis. EClinicalMedicine 2022;54:101689. [PMID: 36267499 DOI: 10.1016/j.eclinm.2022.101689] [Reference Citation Analysis]
43 Donroe JH, Edelman EJ. Alcohol Use. Ann Intern Med 2022. [PMID: 36215713 DOI: 10.7326/AITC202210180] [Reference Citation Analysis]
44 Ha Y, Jeong I, Kim TH. Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives. Biomedicines 2022;10:2530. [PMID: 36289791 DOI: 10.3390/biomedicines10102530] [Reference Citation Analysis]
45 Ko J, Al-Ani Z, Long K, Tarrant C, Skudder-Hill L, Petrov MS. Intrapancreatic, Liver, and Skeletal Muscle Fat Depositions in First Attack of Acute Pancreatitis Versus Health. Am J Gastroenterol 2022;117:1693-701. [PMID: 35971231 DOI: 10.14309/ajg.0000000000001951] [Reference Citation Analysis]
46 Ali N, Ferrao K, Mehta KJ. Liver Iron Loading in Alcohol-Associated Liver Disease. The American Journal of Pathology 2022. [DOI: 10.1016/j.ajpath.2022.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ng CH, Huang DQ, Nguyen MH. Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name. Clin Mol Hepatol 2022;28:790-801. [PMID: 35545437 DOI: 10.3350/cmh.2022.0070] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
48 Geng CX, Gudur AR, Patterson DR, Stotts MJ. Concordance of ICD-10 Codes and the Clinical Diagnosis of Alcoholic Hepatitis. Am J Gastroenterol 2022;117:1706-8. [PMID: 35973184 DOI: 10.14309/ajg.0000000000001886] [Reference Citation Analysis]
49 Bajaj JS, Nagy LE. Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care. Gastroenterology 2022;163:840-51. [PMID: 35598629 DOI: 10.1053/j.gastro.2022.05.031] [Reference Citation Analysis]
50 Garbuzenko DV. Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis. Arhivʺ vnutrennej mediciny 2022;12:352-362. [DOI: 10.20514/2226-6704-2022-12-5-352-362] [Reference Citation Analysis]
51 Wakil A, Mohamed M, Tafesh Z, Niazi M, Olivo R, Xia W, Greenberg P, Pyrsopoulos N. Trends in hospitalization for alcoholic hepatitis from 2011 to 2017: A USA nationwide study. World J Gastroenterol 2022; 28(34): 5036-5046 [DOI: 10.3748/wjg.v28.i34.5036] [Reference Citation Analysis]
52 Alexandre W, Muhammad H, Agbalajobi O, Zhang G, Gmelin T, Adejumo A, Noll A, Jonassaint N, Dimartini A, Bataller R, Rogal S. Hepatology-led alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis.. [DOI: 10.21203/rs.3.rs-1923413/v1] [Reference Citation Analysis]
53 Wang X, Huang A, Lu Y, Gao S, Hu W, Cheng H. Drug-induced liver injury associated with dacomitinib: A case report. Front Oncol 2022;12:979462. [PMID: 36185261 DOI: 10.3389/fonc.2022.979462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Ma J, Kumar V, Mahato RI. Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease. Pharmaceutics 2022;14:1894. [DOI: 10.3390/pharmaceutics14091894] [Reference Citation Analysis]
55 Kaze E, Henrion J. 5-year mortality of alcohol-related cirrhosis: patients die just as much but not in the same manner. AGEB 2022;85:447-451. [DOI: 10.51821/85.3.9644] [Reference Citation Analysis]
56 Lim N, Kwong AJ, Jafri SM, Jesse MT, Kriss M, Nair K, Pillai A, Shingina A, Tang Q, Desai AP. Heterogeneity in Center Practices in Liver Transplantation for Alcohol-Associated Liver Disease in the United States. Am J Gastroenterol 2022;117:1530-5. [PMID: 35916539 DOI: 10.14309/ajg.0000000000001863] [Reference Citation Analysis]
57 Lim SZ, Chuah KH, Rajaram RB, Stanley K, Shahrani S, Chan WK, Ho SH, Hilmi IN, Goh KL, Mahadeva S. Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study. J Gastroenterol Hepatol 2022;37:1732-40. [PMID: 35637160 DOI: 10.1111/jgh.15905] [Reference Citation Analysis]
58 Lee BP, Terrault NA. Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy. Gastroenterology 2022;163:539-42. [PMID: 35577123 DOI: 10.1053/j.gastro.2022.05.013] [Reference Citation Analysis]
59 Panchal SA, Kaplan DE, Goldberg DS, Mahmud N. Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis. Dig Dis Sci 2022;67:4395-402. [PMID: 35022905 DOI: 10.1007/s10620-021-07321-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Virovic-Jukic L, Ljubas D, Stojsavljevic-Shapeski S, Ljubičić N, Filipec Kanizaj T, Mikolasevic I, Grgurevic I. Liver regeneration as treatment target for severe alcoholic hepatitis. World J Gastroenterol 2022; 28(32): 4557-4573 [DOI: 10.3748/wjg.v28.i32.4557] [Reference Citation Analysis]
61 Vannier AGL, Przybyszewski EM, Shay J, Patel SJ, Schaefer E, Goodman RP, Luther J. Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00765-0. [PMID: 35964893 DOI: 10.1016/j.cgh.2022.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Schomerus G, Leonhard A, Manthey J, Morris J, Neufeld M, Kilian C, Speerforck S, Winkler P, Corrigan PW. The stigma of alcohol-related liver disease and its impact on healthcare. J Hepatol 2022;77:516-24. [PMID: 35526787 DOI: 10.1016/j.jhep.2022.04.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
63 Ma J, Guillot A, Yang Z, Mackowiak B, Hwang S, Park O, Peiffer BJ, Ahmadi AR, Melo L, Kusumanchi P, Huda N, Saxena R, He Y, Guan Y, Feng D, Sancho-Bru P, Zang M, Cameron AM, Bataller R, Tacke F, Sun Z, Liangpunsakul S, Gao B. Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure. J Clin Invest 2022;132:e157780. [PMID: 35838051 DOI: 10.1172/JCI157780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Barman B, Roy A, Nune A, Lyngdoh WV, Jamil M, Tiewsoh I. Epidemiology, clinical, and laboratory profile of patients with hepatitis C: A prospective, observational study from north-eastern India. Trop Doct 2022;:494755221110636. [PMID: 35833220 DOI: 10.1177/00494755221110636] [Reference Citation Analysis]
65 Guo L, Guan Q, Duan W, Ren Y, Zhang X, Xu H, Shi J, Wang F, Lu R, Zhang H, Xu Z, Li H, Geng Y. Dietary Goji Shapes the Gut Microbiota to Prevent the Liver Injury Induced by Acute Alcohol Intake. Front Nutr 2022;9:929776. [DOI: 10.3389/fnut.2022.929776] [Reference Citation Analysis]
66 Creazzo J. Understanding the Silent Killer: A Review of NIAAA, the National Institute on Alcohol Abuse and Alcoholism. Journal of Consumer Health on the Internet 2022;26:293-9. [DOI: 10.1080/15398285.2022.2100167] [Reference Citation Analysis]
67 Rattan P, Shah VH. Review article: current and emerging therapies for acute alcohol-associated hepatitis. Aliment Pharmacol Ther 2022;56:28-40. [PMID: 35567372 DOI: 10.1111/apt.16969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
68 Berlakovich G. Indikationen und Kontraindikationen zur Lebertransplantation in Bezug auf aktuelle Leitlinien. J Gastroenterol Hepatol Erkr 2022;20:38-44. [DOI: 10.1007/s41971-022-00125-0] [Reference Citation Analysis]
69 Shafqat M, Jo JH, Moon HH, Choi YI, Shin DH. Alcohol-related liver disease and liver transplantation. KMJ 2022;37:107-118. [DOI: 10.7180/kmj.22.108] [Reference Citation Analysis]
70 Verma N, Singh S, Roy A, Valsan A, Garg P, Pradhan P, Chakrabarti A, Singh M. Cirrhosis and fungal infections-a cocktail for catastrophe: A systematic review and meta-analysis with machine learning. Mycoses 2022. [PMID: 35713607 DOI: 10.1111/myc.13482] [Reference Citation Analysis]
71 Daniel KE, Matthews LA, Deiss-Yehiely N, Myers J, Garvey M, Rice JP, Eickhoff J, Lucey MR. Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol-Related Liver Disease. Liver Transpl 2022;28:936-44. [PMID: 34596955 DOI: 10.1002/lt.26324] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
72 Szabo G, Thursz M, Shah VH. Therapeutic advances in alcohol-associated hepatitis. J Hepatol 2022;76:1279-90. [PMID: 35589250 DOI: 10.1016/j.jhep.2022.03.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Testino G. Letter to the editor: Chronic liver disease among adolescents and young adults: Alcohol use disorder identification. Hepatology 2022;75:1662-3. [PMID: 35076964 DOI: 10.1002/hep.32360] [Reference Citation Analysis]
74 Driggers KE, Sadowski BW, Shagla E, Kwok RM. Care of the Hepatology Patient in the COVID-19 Era. Curr Hepatology Rep 2022;21:9-20. [DOI: 10.1007/s11901-021-00581-x] [Reference Citation Analysis]
75 Vélez Aguirre JD, Lepesqueur Guillén LH, Yepes Barreto IDJ. La esteatohepatitis no alcohólica: una causa emergente de cirrosis en Colombia. Rev colomb Gastroenterol 2022;37:136-144. [DOI: 10.22516/25007440.783] [Reference Citation Analysis]
76 Aghemo A, Alekseeva OP, Angelico F, Bakulin IG, Bakulina NV, Bordin D, Bueverov AO, Drapkina OM, Gillessen A, Kagarmanova EM, Korochanskaya NV, Kucheryavii UA, Lazebnik LB, Livzan MA, Maev IV, Martynov AI, Osipenko MF, Sas EI, Starodubova A, Uspensky YP, Vinnitskaya EV, Yakovenko EP, Yakovlev AA. Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review. Annals of Medicine 2022;54:1548-60. [DOI: 10.1080/07853890.2022.2069854] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
77 Bachrach RL, Rogal SS. Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease. Clin Liver Dis (Hoboken) 2022;20:61-5. [PMID: 36033430 DOI: 10.1002/cld.1203] [Reference Citation Analysis]
78 Holmes R, Patel A, Desai AP. Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease. Clin Liver Dis (Hoboken) 2022;20:32-7. [PMID: 36033426 DOI: 10.1002/cld.1204] [Reference Citation Analysis]
79 Yang W, Singla R, Maheshwari O, Fontaine CJ, Gil-mohapel J. Alcohol Use Disorder: Neurobiology and Therapeutics. Biomedicines 2022;10:1192. [DOI: 10.3390/biomedicines10051192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Zdanowicz K, Kowalczuk-kryston M, Olanski W, Werpachowska I, Mielech W, Lebensztejn DM. Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents—A Preliminary Study. Biomolecules 2022;12:710. [DOI: 10.3390/biom12050710] [Reference Citation Analysis]
81 Ikonnikova KA, Eroshchenko NN, Drozdov VN, Shikh EV, Serebrova SY. Debating capabilities of biochemical markers of liver function in patients with alcoholic liver cirrhosis. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-7-76-83] [Reference Citation Analysis]
82 Hurtado-Navarro L, Angosto-Bazarra D, Pelegrín P, Baroja-Mazo A, Cuevas S. NLRP3 Inflammasome and Pyroptosis in Liver Pathophysiology: The Emerging Relevance of Nrf2 Inducers. Antioxidants (Basel) 2022;11:870. [PMID: 35624734 DOI: 10.3390/antiox11050870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Cabezas J. Management of Alcohol-Related Liver Disease and Its Complications. Clin Drug Investig 2022. [PMID: 35467296 DOI: 10.1007/s40261-022-01143-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Way GW, Jackson KG, Muscu SR, Zhou H. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids. Cells 2022;11:1374. [PMID: 35456053 DOI: 10.3390/cells11081374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
85 Leggio L, Mellinger JL. Alcohol use disorder in community management of chronic liver diseases. Hepatology 2022. [PMID: 35434815 DOI: 10.1002/hep.32531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
86 Arab JP, Atkinson SR, Bataller R. Alcohol‐related liver disease. Yamada's Textbook of Gastroenterology 2022. [DOI: 10.1002/9781119600206.ch95] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Inukai Y, Imai N, Yamamoto K, Ito T, Ishizu Y, Honda T, Okamoto S, Kanematsu T, Suzuki N, Matsushita T, Ishigami M, Fujishiro M. The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia. Ann Hepatol 2022;27:100545. [PMID: 34571264 DOI: 10.1016/j.aohep.2021.100545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Tien HM, Cheng TC, Lien HC, Yang KF, Shy CG, Chen YL, Hsu NT, Lu SN, Wang JH. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care. Int J Environ Res Public Health 2022;19:3269. [PMID: 35328957 DOI: 10.3390/ijerph19063269] [Reference Citation Analysis]
89 Habash NW, Sehrawat TS, Shah VH, Cao S. Epigenetics of alcohol-related liver diseases. JHEP Rep 2022;4:100466. [PMID: 35462859 DOI: 10.1016/j.jhepr.2022.100466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
90 Ren R, He Y, Ding D, Cui A, Bao H, Ma J, Hou X, Li Y, Feng D, Li X, Liangpunsakul S, Gao B, Wang H. Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C/EBPα-miRNA-223 axis. Hepatology 2022;75:646-60. [PMID: 34510484 DOI: 10.1002/hep.32152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
91 Yang Y, Wang X, Cao J, Li J. Clinical characteristics and survival analysis of liver transplantation in patients with alcoholic liver disease: A single-center retrospective study. Transplant Immunology 2022. [DOI: 10.1016/j.trim.2022.101569] [Reference Citation Analysis]
92 Osna NA, Eguchi A, Feldstein AE, Tsukamoto H, Dagur RS, Ganesan M, New-Aaron M, Arumugam MK, Chava S, Ribeiro M, Szabo G, Mueller S, Wang S, Chen C, Weinman SA, Kharbanda KK. Cell-to-Cell Communications in Alcohol-Associated Liver Disease. Front Physiol 2022;13:831004. [PMID: 35264978 DOI: 10.3389/fphys.2022.831004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
93 Johnson E, Ghosh SM, Daniels VJ, Wild TC, Tandon P, Hyde A. Clinicians' perspectives and perceived barriers to caring for patients with alcohol use disorder and cirrhosis. Addict Sci Clin Pract 2022;17:9. [PMID: 35139919 DOI: 10.1186/s13722-022-00292-8] [Reference Citation Analysis]
94 Madathanapalli A, Tang Q, Lammert C, Samala N, Shah VH, Sanyal A, Chalasani N, Desai AP. Health-related quality of life is dynamic in alcoholic hepatitis and responds to improvement in liver disease and reduced alcohol consumption. Alcohol Clin Exp Res 2022;46:252-61. [PMID: 34862610 DOI: 10.1111/acer.14756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2022;20:409-418.e5. [PMID: 33279780 DOI: 10.1016/j.cgh.2020.11.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
96 Bajaj JS, O'Leary JG, Lai JC, Wong F, Long MD, Wong RJ, Kamath PS. Acute-on-Chronic Liver Failure Clinical Guidelines. Am J Gastroenterol 2022;117:225-52. [PMID: 35006099 DOI: 10.14309/ajg.0000000000001595] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
97 Sinn DH, Kang D, Guallar E, Hong YS, Cho J, Gwak G. Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study. BMC Med 2022;20. [DOI: 10.1186/s12916-021-02215-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
98 Matthews LA, Lucey MR. Psychosocial Evaluation in Liver Transplantation for Patients with Alcohol-Related Liver Disease. Clin Liver Dis (Hoboken) 2022;19:17-20. [PMID: 35106144 DOI: 10.1002/cld.1160] [Reference Citation Analysis]
99 Xing M, Gao M, Li J, Han P, Mei L, Zhao L. Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases. Medicine (Baltimore) 2022;101:e28443. [PMID: 35029891 DOI: 10.1097/MD.0000000000028443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Aby ES, Lake JR. The Rush to Early Liver Transplantation for Alcoholic Hepatitis-Potential Financial Implications. Liver Transpl 2022;28:9-10. [PMID: 34455686 DOI: 10.1002/lt.26282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Haque LY, Fiellin DA. Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases. Dig Dis Sci 2022;67:2721-6. [PMID: 35430700 DOI: 10.1007/s10620-022-07478-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
102 Winder GS, Fernandez AC, Mellinger JL. Integrated Care of Alcohol-Related Liver Disease. J Clin Exp Hepatol 2022;12:1069-82. [PMID: 35814517 DOI: 10.1016/j.jceh.2022.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
103 Bhavsar-Burke I, Guardiola JJ, Holden JH. Is Blood Transfusion a Means of False Positive Phosphatidylethanol Testing? Liver Transpl 2022;28:138-9. [PMID: 34519152 DOI: 10.1002/lt.26297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Ayares G, Idalsoaga F, Díaz LA, Arnold J, Arab JP. Current Medical Treatment for Alcohol-Associated Liver Disease. J Clin Exp Hepatol 2022;12:1333-48. [PMID: 36157148 DOI: 10.1016/j.jceh.2022.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
105 Arab JP, Izzy M, Leggio L, Bataller R, Shah VH. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol 2022;19:45-59. [PMID: 34725498 DOI: 10.1038/s41575-021-00527-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
106 Singh H, Singh T, Buttar HS, Kaur S, Arora S, Télessy IG, Singh B. The Pathophysiology of Liver Disorders and Pharmacotherapy Options with Special Reference to Traditional Herbal Medicines: A Comprehensive Review. Biomedical Translational Research 2022. [DOI: 10.1007/978-981-16-9232-1_29] [Reference Citation Analysis]
107 Kaushal K, Agarwal S, Sharma S, Goswami P, Singh N, Sachdev V, Poudel S, Das P, Yadav R, Kumar D, Pandey G, Gunjan D, Saraya A. Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study. J Clin Exp Hepatol 2022;12:1102-13. [PMID: 35814507 DOI: 10.1016/j.jceh.2022.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Thompson J, Karnsakul W. Liver disorders: nutritional management. Reference Module in Food Science 2022. [DOI: 10.1016/b978-0-12-821848-8.00171-2] [Reference Citation Analysis]
109 Khan S, Cain O, Rajoriya N. Alcohol Related Liver Disease. Men’s Health and Wellbeing 2022. [DOI: 10.1007/978-3-030-84752-4_11] [Reference Citation Analysis]
110 Kumar SE, Goel A, Zachariah U, Nair SC, David VG, Varughese S, Gandhi PB, Barpha A, Sharma A, Vijayalekshmi B, Balasubramanian KA, Elias E, Eapen CE. Low Volume Plasma Exchange and Low Dose Steroid Improve Survival in Patients With Alcohol-Related Acute on Chronic Liver Failure and Severe Alcoholic Hepatitis - Preliminary Experience. J Clin Exp Hepatol 2022;12:372-8. [PMID: 35535077 DOI: 10.1016/j.jceh.2021.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
111 Philips CA, Arab JP, Qi X, Imai N, Augustine P. Gut Microbiota-Related Clinical Events and Therapeutic Interventions in Alcohol-Associated Liver Disease. Human Microbiome 2022. [DOI: 10.1007/978-981-16-7672-7_6] [Reference Citation Analysis]
112 Ferrao K, Ali N, Mehta KJ. Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects. J Mol Med (Berl) 2022;100:1673-89. [PMID: 36214835 DOI: 10.1007/s00109-022-02254-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Neuberger J. Long-term Care of the Adult Liver Transplant Recipient. J Clin Exp Hepatol 2022;12:1547-56. [PMID: 36340310 DOI: 10.1016/j.jceh.2022.03.012] [Reference Citation Analysis]
114 Iacob S, Gheorghe L. Indications for Liver Transplantation in Adults: Selection of Patients with End Stage Liver Diseases. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases 2022. [DOI: 10.1007/978-981-19-0063-1_61] [Reference Citation Analysis]
115 O’gurek DT. Diseases of the Liver. Family Medicine 2022. [DOI: 10.1007/978-3-030-54441-6_97] [Reference Citation Analysis]
116 Im GY, Vogel AS, Florman S, Nahas J, Friedman SL, Aqui S, Ford L, Mirza O, Kim-Schluger L, Schiano TD. Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis. Liver Transpl 2022;28:27-38. [PMID: 34133847 DOI: 10.1002/lt.26215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
117 Majumdar A, Tsochatzis EA. Binge drinking and fibrogenesis: More than just a hangover. Liver Int 2022;42:6-8. [PMID: 34965015 DOI: 10.1111/liv.15119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
118 Gillessen A, Angelico F, Chen J, Lu L, Lucena MI, Fu Q, Xie Q, Andrade RJ, Xie W, Xu X, Yu Y, Mao Y, Nan Y. Silymarin for Treating Toxic Liver Disease: International Consensus Recommendations. Gastro Hep Advances 2022;1:882-893. [DOI: 10.1016/j.gastha.2022.05.006] [Reference Citation Analysis]
119 Fan M, Wang Y, Jin L, Fang Z, Peng J, Tu J, Liu Y, Zhang E, Xu S, Liu X, Huo Y, Sun Z, Chao X, Ding WX, Yan Q, Huang W. Bile Acid-Mediated Activation of Brown Fat Protects From Alcohol-Induced Steatosis and Liver Injury in Mice. Cell Mol Gastroenterol Hepatol 2022;13:809-26. [PMID: 34896286 DOI: 10.1016/j.jcmgh.2021.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
120 Patidar KR, Peng JL, Kaur H, Worden A, Kettler CD, Pike F, Buckley CA, Orman ES, Desai AP, Nephew LD, Kubal CA, Gawrieh S, Chalasani N, Ghabril MS. Severe Alcohol-Associated Hepatitis Is Associated With Worse Survival in Critically Ill Patients With Acute on Chronic Liver Failure. Hepatol Commun 2021. [PMID: 34860462 DOI: 10.1002/hep4.1874] [Reference Citation Analysis]
121 Lazo M, Bilal U, Mitchell MC, Potter J, Hernaez R, Clark JM. Interaction Between Alcohol Consumption and PNPLA3 Variant in the Prevalence of Hepatic Steatosis in the US Population. Clin Gastroenterol Hepatol 2021;19:2606-2614.e4. [PMID: 32882427 DOI: 10.1016/j.cgh.2020.08.054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
122 German MN, Brown R, Lucey MR. Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease. Gastroenterology 2021;161:1795-7. [PMID: 34563475 DOI: 10.1053/j.gastro.2021.09.041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Winters AC, May FP, Wang Y, Shao P, Yang L, Patel AA. Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis. Drug and Alcohol Dependence Reports 2021;1:100004. [DOI: 10.1016/j.dadr.2021.100004] [Reference Citation Analysis]
124 Carrique L, Quance J, Tan A, Abbey S, Sales I, Lilly L, Bhat M, Galvin Z, Cattral M, Ghanekar A, McGilvray I, Reichman T, Sapisochin G, Sayed B, Selzner M, Lynch MJ, Selzner N. Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment With Low Rate of Relapse. Gastroenterology 2021;161:1896-1906.e2. [PMID: 34370999 DOI: 10.1053/j.gastro.2021.08.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
125 Cohen SM, Alexander RS, Holt SR. The Spectrum of Alcohol Use: Epidemiology, Diagnosis, and Treatment. Med Clin North Am 2022;106:43-60. [PMID: 34823734 DOI: 10.1016/j.mcna.2021.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
126 Zhou J, Chen S, Zhang L, Zhai Y. Successful treatment of acute-on-chronic liver failure secondary to alcoholic cirrhosis with glucocorticoids and albumin: a case report. Daru 2021. [PMID: 34817844 DOI: 10.1007/s40199-021-00420-w] [Reference Citation Analysis]
127 Rehman A, Mehta KJ. Betaine in ameliorating alcohol-induced hepatic steatosis. Eur J Nutr 2021. [PMID: 34817678 DOI: 10.1007/s00394-021-02738-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
128 Kim RG, Medina SP, Magee C, Khalili M. Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations. Hepatol Commun 2021. [PMID: 34792300 DOI: 10.1002/hep4.1873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol 2021;75:1026-33. [PMID: 34166722 DOI: 10.1016/j.jhep.2021.06.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
130 Im GY, Mellinger JL, Winters A, Aby ES, Lominadze Z, Rice J, Lucey MR, Arab JP, Goel A, Jophlin LL, Sherman CB, Parker R, Chen PH, Devuni D, Sidhu S, Dunn W, Szabo G, Singal AK, Shah VH. Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group. Clin Gastroenterol Hepatol 2021;19:2407-2416.e8. [PMID: 33069880 DOI: 10.1016/j.cgh.2020.10.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
131 Melis M, Tang XH, Attarwala N, Chen Q, Prishker C, Qin L, Gross SS, Gudas LJ, Trasino SE. A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes. Biofactors 2021. [PMID: 34687254 DOI: 10.1002/biof.1794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
132 Masson S, Aldersley H, Leithead JA, Day E, Langford A, Healy P, O'Grady J, Thorburn D, Parker C, Shepherd L, Arndtz K, Webb K, Holt A. Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral. Lancet Gastroenterol Hepatol 2021;6:947-55. [PMID: 34626562 DOI: 10.1016/S2468-1253(21)00195-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
133 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 84] [Cited by in F6Publishing: 99] [Article Influence: 42.0] [Reference Citation Analysis]
134 Sharma SP, Suk KT, Kim DJ. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J Gastroenterol 2021; 27(37): 6161-6179 [PMID: 34712025 DOI: 10.3748/wjg.v27.i37.6161] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
135 Pearson MM, Kim NJ, Berry K, Moon AM, Su F, Vutien P, Green PK, Williams EC, Ioannou GN. Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis. Hepatol Commun 2021;5:2080-95. [PMID: 34601829 DOI: 10.1002/hep4.1776] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
136 Musto JA, Eickhoff J, Ventura-Cots M, Abraldes JG, Bosques-Padilla F, Verna EC, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross D, Louvet A, Mathurin P, Garcia-Tsao G, Schnabl B, Bataller R, Lucey MR. The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated Hepatitis. Liver Transpl 2021;27:1382-91. [PMID: 34109723 DOI: 10.1002/lt.26203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Vilarinho S, Ajmera V, Zheng M, Loomba R. Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD. Hepatology 2021;74:2241-50. [PMID: 34233030 DOI: 10.1002/hep.32047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
138 Petagine L, Zariwala MG, Patel VB. Alcoholic liver disease: Current insights into cellular mechanisms. World J Biol Chem 2021; 12(5): 87-103 [PMID: 34630912 DOI: 10.4331/wjbc.v12.i5.87] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
139 Litwinowicz K, Waszczuk E, Gamian A. Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis. Nutrients 2021;13:3370. [PMID: 34684371 DOI: 10.3390/nu13103370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Gougol A, Clemente-Sanchez A, Argemi J, Bataller R. Alcoholic Hepatitis. Clin Liver Dis (Hoboken) 2021;18:90-5. [PMID: 34584675 DOI: 10.1002/cld.1092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Warner J, Hardesty J, Song Y, Sun R, Deng Z, Xu R, Yin X, Zhang X, McClain C, Warner D, Kirpich I. Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration. Front Pharmacol 2021;12:711590. [PMID: 34531743 DOI: 10.3389/fphar.2021.711590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
142 Mathurin P. Early liver transplantation for acute alcoholic hepatitis: We can't say no. J Hepatol 2021;75:718-22. [PMID: 34058297 DOI: 10.1016/j.jhep.2021.05.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
143 Niezen S, Trivedi HD, Mukamal KJ, Jiang ZG. Associations between alcohol consumption and hepatic steatosis in the USA. Liver Int 2021;41:2020-3. [PMID: 34297882 DOI: 10.1111/liv.15020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
144 Shamseddeen H, Madathanapalli A, Are VS, Shah VH, Sanyal AJ, Tang Q, Liang T, Gelow K, Zimmers TA, Chalasani N, Desai AP. Changes in Serum Myostatin Levels in Alcoholic Hepatitis Correlate with Improvement in MELD. Dig Dis Sci 2021;66:3062-73. [PMID: 33074470 DOI: 10.1007/s10620-020-06632-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Qian M, Liu J, Zhao D, Cai P, Pan C, Jia W, Gao Y, Zhang Y, Zhang N, Zhang Y, Zhang Q, Wu D, Shan C, Zhang M, Schnabl B, Yang S, Shen X, Wang L. Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease. Cell Mol Gastroenterol Hepatol 2022;13:233-56. [PMID: 34454169 DOI: 10.1016/j.jcmgh.2021.08.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
146 Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, Krach MR, Anders RA, Gurakar A, Chen PH, Segev DL, King EA, Philosophe B, Ottman SE, Wesson RN, Garonzik-Wang JM, Cameron AM. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA Surg 2021. [PMID: 34379106 DOI: 10.1001/jamasurg.2021.3748] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
147 Yoshimura Y, Hamaguchi M, Hashimoto Y, Okamura T, Nakanishi N, Obora A, Kojima T, Fukui M. Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study. BMC Gastroenterol 2021;21:321. [PMID: 34372774 DOI: 10.1186/s12876-021-01893-4] [Reference Citation Analysis]
148 Bertha M, Choi G, Mellinger J. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Patient-Friendly Summary of the 2019 AASLD Guidelines. Clin Liver Dis (Hoboken) 2021;17:418-23. [PMID: 34386207 DOI: 10.1002/cld.1129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Maddur H. Current Therapies for Alcohol-Associated Hepatitis. Clin Liver Dis 2021;25:595-602. [PMID: 34229842 DOI: 10.1016/j.cld.2021.03.005] [Reference Citation Analysis]
150 Rutledge SM, Im GY. Current and Future Biomarkers in Alcoholic Hepatitis. Clin Liver Dis 2021;25:493-516. [PMID: 34229836 DOI: 10.1016/j.cld.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Clemente-Sánchez A, Oliveira-Mello A, Bataller R. Moderate Alcoholic Hepatitis. Clin Liver Dis 2021;25:537-55. [PMID: 34229838 DOI: 10.1016/j.cld.2021.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Ting PS, Gurakar A, Wheatley J, Chander G, Cameron AM, Chen PH. Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis. Clin Liver Dis 2021;25:645-71. [PMID: 34229846 DOI: 10.1016/j.cld.2021.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Singal AK, Arsalan A, Dunn W, Arab JP, Wong RJ, Kuo YF, Kamath PS, Shah VH. Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics. Aliment Pharmacol Ther 2021;54:451-61. [PMID: 34247424 DOI: 10.1111/apt.16461] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
154 Arab JP, Arrese M, Singal AK. Diagnosis of Alcohol-Associated Hepatitis: When Is Liver Biopsy Required? Clin Liver Dis 2021;25:571-84. [PMID: 34229840 DOI: 10.1016/j.cld.2021.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
155 Zhang Y, Fan Y, He W, Han Y, Bao H, Yang R, Wang B, Kong D, Wang H. Persistent deficiency of mucosa-associated invariant T (MAIT) cells during alcohol-related liver disease. Cell Biosci 2021;11:148. [PMID: 34321090 DOI: 10.1186/s13578-021-00664-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
156 Verma N, Singh S, Syal A, Pradhan P, Singh M, Singh M. Invasive aspergillosis is a critical determinant of mortality in cirrhosis: a systematic review with meta-analysis. Med Mycol 2021:myab044. [PMID: 34308965 DOI: 10.1093/mmy/myab044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
157 Shibamoto A, Namisaki T, Suzuki J, Kubo T, Iwai S, Tomooka F, Takeda S, Fujimoto Y, Enomoto M, Murata K, Inoue T, Ishida K, Ogawa H, Takagi H, Kaya D, Tsuji Y, Ozutsumi T, Fujinaga Y, Furukawa M, Nishimura N, Sawada Y, Kitagawa K, Sato S, Takaya H, Kaji K, Shimozato N, Kawaratani H, Moriya K, Akahane T, Mitoro A, Yoshiji H. Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis. Medicines (Basel) 2021;8:39. [PMID: 34357155 DOI: 10.3390/medicines8070039] [Reference Citation Analysis]
158 Song DS. [Medical Treatment of Alcoholic Liver Disease]. Korean J Gastroenterol 2020;76:65-70. [PMID: 32839368 DOI: 10.4166/kjg.2020.76.2.65] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
159 Chen PH, Ting PS, Almazan E, Chander G, Cameron AM, Gurakar A. Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic. Alcohol Alcohol 2021:agab047. [PMID: 34219147 DOI: 10.1093/alcalc/agab047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
160 Jepsen P, Younossi ZM. The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs. J Hepatol 2021;75 Suppl 1:S3-S13. [PMID: 34039490 DOI: 10.1016/j.jhep.2020.11.042] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
161 Nawroth JC, Petropolis DB, Manatakis DV, Maulana TI, Burchett G, Schlünder K, Witt A, Shukla A, Kodella K, Ronxhi J, Kulkarni G, Hamilton G, Seki E, Lu S, Karalis KC. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Rep 2021;36:109393. [PMID: 34289365 DOI: 10.1016/j.celrep.2021.109393] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
162 Lamm K, McCarter M, Russo MW. Is There a Futility Discriminant Function Score for Alcoholic Hepatitis? J Clin Med 2021;10:2756. [PMID: 34201606 DOI: 10.3390/jcm10132756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Liu J, Zhou H, Song L, Yang Z, Qiu M, Wang J, Shi S. Anthocyanins: Promising Natural Products with Diverse Pharmacological Activities. Molecules 2021;26:3807. [PMID: 34206588 DOI: 10.3390/molecules26133807] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
164 Гришенкова Л. Biomarkers of Alcohol Use and Abuse: Role in Diagnosticsand Retrospective Assessment of Chronic Alcohol Intoxication. Лабораторная диагностика. Восточная Европа 2021. [DOI: 10.34883/pi.2021.10.2.008] [Reference Citation Analysis]
165 Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. Hepatol Commun 2021;5:1616-21. [PMID: 34510833 DOI: 10.1002/hep4.1747] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
166 Avanceña ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021;74:1286-94. [PMID: 33326815 DOI: 10.1016/j.jhep.2020.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
167 Johnson AL, Hayward KL. Managing medicines in alcohol-associated liver disease: a practical review. Aust Prescr 2021;44:96-106. [PMID: 34211248 DOI: 10.18773/austprescr.2021.015] [Reference Citation Analysis]
168 Louvet A. Cirrosis asociada al alcohol. EMC - Tratado de Medicina 2021;25:1-6. [DOI: 10.1016/s1636-5410(21)45114-7] [Reference Citation Analysis]
169 Bhavsar-Burke I, Jansson-Knodell CL, Gilmore AC, Crabb DW. Review article: the role of nutrition in alcohol-associated liver disease. Aliment Pharmacol Ther 2021;53:1268-76. [PMID: 33896017 DOI: 10.1111/apt.16380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
170 Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585 [PMID: 34092976 DOI: 10.3748/wjg.v27.i20.2576] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
171 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
172 Eriksen CS, Kimer N, Suetta C, Møller S. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G729-40. [PMID: 33729006 DOI: 10.1152/ajpgi.00478.2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
173 Asrani SK, Mellinger J, Arab JP, Shah VH. Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action. Hepatology 2021;73:2039-50. [PMID: 32986883 DOI: 10.1002/hep.31583] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
174 German MN, Musto J, Lucey MR. Novel treatments for alcoholic hepatitis. Curr Opin Gastroenterol 2021;37:179-86. [PMID: 33769374 DOI: 10.1097/MOG.0000000000000725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Buchanan R, Sinclair JMA. Alcohol use disorder and the liver. Addiction 2021;116:1270-8. [PMID: 32710592 DOI: 10.1111/add.15204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
176 Ashraf H, Karbalai S, Jamali R. Nonalcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration. WJMA 2021;9:163-74. [DOI: 10.13105/wjma.v9.i2.163] [Reference Citation Analysis]
177 Ashraf H, Karbalai S, Jamali R. Nonalcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration. World J Meta-Anal 2021; 9(2): 164-175 [DOI: 10.13105/wjma.v9.i2.164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Kim BY, Nam H, Yoo JJ, Cho YY, Choi DH, Jung CH, Mok JO, Kim CH. Association between alcohol consumption status and obesity-related comorbidities in men: data from the 2016 Korean community health survey. BMC Public Health 2021;21:733. [PMID: 33858402 DOI: 10.1186/s12889-021-10776-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
179 Mellinger JL, Winder GS, Fernandez AC, Klevering K, Johnson A, Asefah H, Figueroa M, Buchanan J, Blow F, Lok ASF. Feasibility and early experience of a novel multidisciplinary alcohol-associated liver disease clinic. J Subst Abuse Treat 2021;130:108396. [PMID: 34118717 DOI: 10.1016/j.jsat.2021.108396] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
180 Yan R, Chu J, Zhou Y, Shan W, Hu Y, Lin M, Zhao Y, Sun R, Wang Z, Lv L, Wang L, Yao J, Zhang N. Ubiquitin-specific protease 22 ameliorates chronic alcohol-associated liver disease by regulating BRD4. Pharmacol Res 2021;168:105594. [PMID: 33826947 DOI: 10.1016/j.phrs.2021.105594] [Reference Citation Analysis]
181 Rumbolt C, Minuk GY. The effects of binge drinking on healthy and diseased livers. CanLivJ 2021;4:93-8. [DOI: 10.3138/canlivj-2020-0037] [Reference Citation Analysis]
182 Kim HI, Park SY, Shin HP. Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study. Sci Rep 2021;11:6648. [PMID: 33758281 DOI: 10.1038/s41598-021-86197-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Fan X, Wu J, Poulsen KL, Kim A, Wu X, Huang E, Miyata T, Sanz-Garcia C, Nagy LE. Identification of a MicroRNA-E3 Ubiquitin Ligase Regulatory Network for Hepatocyte Death in Alcohol-Associated Hepatitis. Hepatol Commun 2021;5:830-45. [PMID: 34027272 DOI: 10.1002/hep4.1677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Rutledge SM, Schiano TD, Florman S, Im GY. COVID-19 Aftershocks on Alcohol-associated Liver Disease: An Early Cross-Sectional Report from the U.S. Epicenter (Manuscript HEP4-20-0491). Hepatol Commun 2021. [PMID: 33821225 DOI: 10.1002/hep4.1706] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
185 Cotter TG, Sandıkçı B, Paul S, Gampa A, Wang J, Te H, Pillai A, Reddy KG, di Sabato D, Little EC, Sundaram V, Fung J, Lucey MR, Charlton M. Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency. Am J Transplant 2021;21:1039-55. [PMID: 32531107 DOI: 10.1111/ajt.16143] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
186 Mellinger J, Winder GS, Fernandez AC. Measuring the Alcohol in Alcohol-Associated Liver Disease: Choices and Challenges for Clinical Research. Hepatology 2021;73:1207-12. [PMID: 32886409 DOI: 10.1002/hep.31539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
187 Verma A, Jensen D. A Case of Rapid Decline in Alcohol-Associated Liver Disease. Clin Liver Dis (Hoboken) 2021;17:67-70. [PMID: 33680438 DOI: 10.1002/cld.997] [Reference Citation Analysis]
188 Beaudoin JJ, Liang T, Tang Q, Banini BA, Shah VH, Sanyal AJ, Chalasani NP, Gawrieh S. Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis. Alcohol Clin Exp Res 2021;45:709-19. [PMID: 33616244 DOI: 10.1111/acer.14581] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
189 Nguepi IST, Ngueguim FT, Gounoue RK, Mbatchou A, Dimo T. Curative effects of the aqueous extract of Tithonia diversifolia (Hemsl.) A. gray (Asteraceae) against ethanol induced-hepatotoxicity in rats. J Basic Clin Physiol Pharmacol 2021;32:1137-43. [PMID: 33561913 DOI: 10.1515/jbcpp-2019-0370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Gupta H, Suk KT, Kim DJ. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver. J Clin Med 2021;10:541. [PMID: 33540624 DOI: 10.3390/jcm10030541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
191 Pimienta M, Dodge J, Terrault NA. The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder. Hepatol Commun 2021;5:155-7. [PMID: 33553965 DOI: 10.1002/hep4.1649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
192 Hause J, Rice JP. Transplants for Acute Alcoholic Hepatitis: Controversies and Early Successes. Clin Liver Dis 2021;25:229-52. [PMID: 33978581 DOI: 10.1016/j.cld.2020.08.010] [Reference Citation Analysis]
193 Sehrawat TS, Arab JP, Liu M, Amrollahi P, Wan M, Fan J, Nakao Y, Pose E, Navarro-Corcuera A, Dasgupta D, Liao CY, He L, Mauer AS, Avitabile E, Ventura-Cots M, Bataller RA, Sanyal AJ, Chalasani NP, Heimbach JK, Watt KD, Gores GJ, Gines P, Kamath PS, Simonetto DA, Hu TY, Shah VH, Malhi H. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis. Hepatology 2021;73:571-85. [PMID: 32246544 DOI: 10.1002/hep.31256] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 16.0] [Reference Citation Analysis]
194 Sinn DH, Kang D, Guallar E, Chang Y, Ryu S, Zhao D, Hong YS, Cho J, Gwak GY. Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study. Am J Gastroenterol 2021;116:329-35. [PMID: 33038136 DOI: 10.14309/ajg.0000000000000966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
195 Huang TH, Lin MT, Wang JH, Chang KC, Yen YH, Kuo FY, Huang CC, Hsiao CC, Chiu SY, Lu SN, Wang CC, Hu TH. Clinical and novel application of FibroScan, FIB-4 and aspartate aminotransferase-to-platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction. Int J Clin Pract 2021;75:e13945. [PMID: 33338308 DOI: 10.1111/ijcp.13945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
196 Charatcharoenwitthaya P, Liangpunsakul S, Piratvisuth T. Alcohol-Associated Liver Disease: East Versus West. Clin Liver Dis (Hoboken) 2020;16:231-5. [PMID: 33489093 DOI: 10.1002/cld.920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
197 Spahr L, Lanthier N, Tihy M, Frossard JL, Rubbia-Brandt L, Goossens N. Clinical Presentation and Gene Expression of Acute Alcohol-Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis. Hepatol Commun 2021;5:618-28. [PMID: 33860120 DOI: 10.1002/hep4.1669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Jiang L, Stärkel P, Fan JG, Fouts DE, Bacher P, Schnabl B. The gut mycobiome: a novel player in chronic liver diseases. J Gastroenterol 2021;56:1-11. [PMID: 33151407 DOI: 10.1007/s00535-020-01740-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
199 Alm M, Andresen V, Ell C, Fibbe C, Fischbach W, Keller J, Frank Kipp P, May A, Miehlke S, Porschen R, Stallmach A, Weinke T, Aehling N, Alm M, Andresen V, Baumgart DC, Bertram F, Böhlig A, Bullmann C, Carstensen J, de Greck M, Ellerbeck W, Enders G, Fibbe C, Fischbach W, Fritz K, Gaus A, Gottschalk L, Grandt KD, Henniges U, Herta T, Jasper D, Keller J, Kschowak N, Lang K, Lange A, Layer P, Liedtke N, Luttermann J, Mancke L, Meier VS, Melle U, Menge D, Michaelis S, Nader S, Niedergassel T, Pachmann C, Porschen R, Rose S, Rosien U, Rössle M, Schellhorn M, Schnell O, Schulz S, Siegel J, Stein A, Szuba J, Teising S, Thiel S, Thomas-morr J, Tillmann H, Todt F, Veelken R, von Schassen H, Wölfel M, Wolf S, Wolgast V, Wübbolding C, Zimmermann K. Leber. Facharztwissen Gastroenterologie und Hepatologie 2021. [DOI: 10.1016/b978-3-437-21252-9.00011-0] [Reference Citation Analysis]
200 Turankova T, Casazza G, Pavlov CS. Transient Elastography for the Diagnosis of Liver Fibrosis and Cirrhosis in People with Alcohol-Associated Liver Disease. Elastography of the Liver and Beyond 2021. [DOI: 10.1007/978-3-030-74132-7_8] [Reference Citation Analysis]
201 Mavilia MG, Wu GY. Hepatitis. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-72592-1_8] [Reference Citation Analysis]
202 Choudhary NS, Saraf N, Mehrotra S, Saigal S, Soin AS. Recidivism in Liver Transplant Recipients for Alcohol-related Liver Disease. J Clin Exp Hepatol 2021;11:387-96. [PMID: 33994719 DOI: 10.1016/j.jceh.2020.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Miller ED, Abu-sbeih H, Chalasani NP. Drug-Induced Liver Injury in Older Adults. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_53] [Reference Citation Analysis]
204 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
205 Kedarisetty CK, Kumar A, Sarin SK. Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis. Semin Liver Dis 2021;41:67-78. [PMID: 33764486 DOI: 10.1055/s-0040-1719177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
206 Hagström H, Thiele M, Roelstraete B, Söderling J, Ludvigsson JF. Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients. Gut 2021;70:170-9. [PMID: 32220902 DOI: 10.1136/gutjnl-2019-320446] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
207 Zhou Q, Wang L, Liu B, Xiao J, Cheng KW, Chen F, Wang M. Tricoumaroylspermidine from rose exhibits inhibitory activity against ethanol-induced apoptosis in HepG2 cells. Food Funct 2021;12:5892-902. [PMID: 34019608 DOI: 10.1039/d1fo00800e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
208 Jüngst C, Kullak-ublick GA. Toxische Lebererkrankungen. Therapie-Handbuch - Gastroenterologie und Hepatologie 2021. [DOI: 10.1016/b978-3-437-23847-5.00049-1] [Reference Citation Analysis]
209 Dinani A, Khan A, Dieterich D. Emerging prevalence of fatty liver disease in HIV. Future Virology 2021;16:59-73. [DOI: 10.2217/fvl-2020-0184] [Reference Citation Analysis]
210 Carey W. Know When to Hold 'em, Know When to Treat 'em, Know When to Cut 'em: Why Severe Alcoholic Hepatitis Is Becoming a Surgical Disease. Dig Dis Sci 2020;65:3431-3. [PMID: 32270305 DOI: 10.1007/s10620-020-06239-w] [Reference Citation Analysis]
211 He Y, Hwang S, Ahmed YA, Feng D, Li N, Ribeiro M, Lafdil F, Kisseleva T, Szabo G, Gao B. Immunopathobiology and therapeutic targets related to cytokines in liver diseases. Cell Mol Immunol 2021;18:18-37. [PMID: 33203939 DOI: 10.1038/s41423-020-00580-w] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
212 Ibrahim EA, Moawed FSM, Moustafa EM. Suppression of inflammatory cascades via novel cinnamic acid nanoparticles in acute hepatitis rat model. Arch Biochem Biophys 2020;696:108658. [PMID: 33144082 DOI: 10.1016/j.abb.2020.108658] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
213 Syed A, Sadler MD, Borman MA, Burak KW, Congly SE. Assessment of Canadian policies regarding liver transplant candidacy of people who use alcohol, tobacco, cannabis, and opiates. CanLivJ 2020;3:372-80. [DOI: 10.3138/canlivj.2020-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
214 Zhang J, Li D, Zhang R, Gao P, Peng R, Li J. The miR-21 potential of serving as a biomarker for liver diseases in clinical practice. Biochem Soc Trans 2020;48:2295-305. [PMID: 33119045 DOI: 10.1042/BST20200653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
215 Mello A, Hsu MF, Koike S, Chu B, Cheng J, Yang J, Morisseau C, Torok NJ, Hammock BD, Haj FG. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease. Cell Mol Gastroenterol Hepatol 2021;11:815-30. [PMID: 33068774 DOI: 10.1016/j.jcmgh.2020.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
216 Noureddin N, Yang JD, Alkhouri N, Noreen SM, Toll AE, Todo T, Ayoub W, Kuo A, Voidonikolas G, Kotler HG, Pelphrey MD, Durand BJ, Kosari K, Brennan TV, Kim I, Klein AS, Seki E, Nissen NN, Lu SC, Sundaram V, Noureddin M. Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 Analysis. Transplant Direct 2020;6:e612. [PMID: 33134488 DOI: 10.1097/TXD.0000000000001051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Dai Y, Jiang Y, Nie Y, Lu Y, Kang M, Jeon Y. Hepato-protective effect of fucoidan extracted from acid-processed Sargassum fusiformis in ethanol-treated Chang liver cells and in a zebrafish model. J Appl Phycol 2020;32:4289-98. [DOI: 10.1007/s10811-020-02262-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
218 Ikejima K, Kon K, Yamashina S. Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights. Clin Mol Hepatol 2020;26:728-35. [PMID: 33053942 DOI: 10.3350/cmh.2020.0202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
219 Kondo R, Iwakiri Y. The lymphatic system in alcohol-associated liver disease. Clin Mol Hepatol 2020;26:633-8. [PMID: 32951411 DOI: 10.3350/cmh.2020.0179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
220 Cotter TG, Ayoub F, King AC, Reddy KG, Charlton M. Practice Habits, Knowledge, and Attitudes of Hepatologists to Alcohol Use Disorder Medication: Sobering Gaps and Opportunities. Transplant Direct 2020;6:e603. [PMID: 33134483 DOI: 10.1097/TXD.0000000000001054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
221 German MN, Eccleston JL, Tamez DA, Remington PL, Lucey MR. Internet Published Policies Regarding Liver Transplant Eligibility and Substance Use in United States Transplant Centers. Hepatol Commun 2020;4:1717-24. [PMID: 33163840 DOI: 10.1002/hep4.1591] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
222 Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int 2020;14:667-76. [PMID: 32892258 DOI: 10.1007/s12072-020-10082-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
223 Pfeiffer RM, Rotman Y, O'Brien TR. Genetic Determinants of Cirrhosis and Hepatocellular Carcinoma Due to Fatty Liver Disease: What's the Score? Hepatology 2020;72:794-6. [PMID: 32506469 DOI: 10.1002/hep.31413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
224 Gellert-Kristensen H, Richardson TG, Davey Smith G, Nordestgaard BG, Tybjaerg-Hansen A, Stender S. Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. Hepatology 2020;72:845-56. [PMID: 32190914 DOI: 10.1002/hep.31238] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 27.7] [Reference Citation Analysis]
225 Da BL, Im GY, Schiano TD. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease. Hepatology 2020;72:1102-8. [PMID: 32369624 DOI: 10.1002/hep.31307] [Cited by in Crossref: 108] [Cited by in F6Publishing: 120] [Article Influence: 36.0] [Reference Citation Analysis]
226 Aehling NF, Seehofer D, Berg T. [Liver transplantation - current trends]. Dtsch Med Wochenschr 2020;145:1124-31. [PMID: 32791547 DOI: 10.1055/a-0982-0737] [Reference Citation Analysis]
227 Zhou Y, Wang S, Wan T, Huang Y, Pang N, Jiang X, Gu Y, Zhang Z, Luo J, Yang L. Cyanidin-3-O-β-glucoside inactivates NLRP3 inflammasome and alleviates alcoholic steatohepatitis via SirT1/NF-κB signaling pathway. Free Radic Biol Med 2020;160:334-41. [PMID: 32805401 DOI: 10.1016/j.freeradbiomed.2020.08.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
228 Dubois M, Sciarra A, Trépo E, Marot A, Saldarriaga J, Moreno C, Sempoux C, Deltenre P. Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis. United European Gastroenterol J 2020;8:1003-12. [PMID: 32778003 DOI: 10.1177/2050640620949737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
229 Frost MC, Ioannou GN, Tsui JI, Edelman EJ, Weiner BJ, Fletcher OV, Williams EC. Practice facilitation to implement alcohol-related care in Veterans Health Administration liver clinics: a study protocol. Implement Sci Commun 2020;1:68. [PMID: 32835226 DOI: 10.1186/s43058-020-00062-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
230 Degré D, Wandji LCN, Moreno C, Louvet A. Alcoholic hepatitis: Towards an era of personalised management. United European Gastroenterol J 2020;8:995-1002. [PMID: 32718222 DOI: 10.1177/2050640620945886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
231 Hu S, Liu YM, Chen-Chen, Li LY, Zhang BY, Yang JF, Li HD, Meng XM, Jun-Li, Xu T, Zhou H. MicroRNA-708 prevents ethanol-induced hepatic lipid accumulation and inflammatory reaction via direct targeting ZEB1. Life Sci 2020;258:118147. [PMID: 32721464 DOI: 10.1016/j.lfs.2020.118147] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
232 Ma J, Cao H, Rodrigues RM, Xu M, Ren T, He Y, Hwang S, Feng D, Ren R, Yang P, Liangpunsakul S, Sun J, Gao B. Chronic-plus-binge alcohol intake induces production of proinflammatory mtDNA-enriched extracellular vesicles and steatohepatitis via ASK1/p38MAPKα-dependent mechanisms. JCI Insight 2020;5:136496. [PMID: 32544093 DOI: 10.1172/jci.insight.136496] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
233 Yu L, Wang L, Yi H, Wu X. Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model. Gut Microbes 2020;11:1015-29. [PMID: 32167008 DOI: 10.1080/19490976.2020.1736457] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
234 Im GY, Neuberger J. Debate on Selection Criteria for Liver Transplantation for Alcoholic Hepatitis: Tighten or Loosen? Liver Transpl 2020;26:916-21. [PMID: 32614520 DOI: 10.1002/lt.25783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
235 Chu H, Jiang L, Gao B, Gautam N, Alamoudi JA, Lang S, Wang Y, Duan Y, Alnouti Y, Cable EE, Schnabl B. The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice. Transl Res 2021;227:1-14. [PMID: 32553670 DOI: 10.1016/j.trsl.2020.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
236 Marot A, Singal AK, Moreno C, Deltenre P. Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials. JHEP Rep 2020;2:100139. [PMID: 32775975 DOI: 10.1016/j.jhepr.2020.100139] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
237 Mellinger JL, Stine JG. Early Liver Transplantation for Severe Alcoholic Hepatitis. Dig Dis Sci 2020;65:1608-14. [PMID: 32107678 DOI: 10.1007/s10620-020-06159-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
238 Hao SR, Zhang SY, Lian JS, Jin X, Ye CY, Cai H, Zhang XL, Hu JH, Zheng L, Zhang YM, Jia HY, Yu GD, Wang XY, Gu JQ, Lu YF, Yu XP, Yu L, Xiang DR, Ye CY, Jin CL, Qiu YQ, Li LJ, Sheng JF, Liang TB, Yang YD. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study. Am J Gastroenterol 2020;115:1075-83. [PMID: 32618658 DOI: 10.14309/ajg.0000000000000717] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
239 Haddadin Y, Katarey D, Sachdeva M, Vickers L, Kaur I, Hashim A, Verma S. Does regulating the sale of high-strength beer and cider impact hospital admissions with decompensated alcohol-related liver disease: A retrospective cohort study. Clin Med 2020;20:308-312. [DOI: 10.7861/clinmed.2019-0390] [Reference Citation Analysis]
240 Glaser T, Baiocchi L, Zhou T, Francis H, Lenci I, Grassi G, Kennedy L, Liangpunsakul S, Glaser S, Alpini G, Meng F. Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: Differences and similarities along the path. J Cell Mol Med. 2020;24:5955-5965. [PMID: 32314869 DOI: 10.1111/jcmm.15182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
241 Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases.Transl Gastroenterol Hepatol. 2020;5:16. [PMID: 32258520 DOI: 10.21037/tgh.2019.09.08] [Cited by in Crossref: 154] [Cited by in F6Publishing: 159] [Article Influence: 51.3] [Reference Citation Analysis]
242 Mahabir CA, Anderson M, Cimino J, Lyden E, Siahpush M, Shiffermiller J. Derivation and validation of a multivariable model, the alcohol withdrawal triage tool (AWTT), for predicting severe alcohol withdrawal syndrome. Drug Alcohol Depend 2020;209:107943. [PMID: 32172129 DOI: 10.1016/j.drugalcdep.2020.107943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
243 Tubío AF, Cobo JR, Villajos LT, Martín-mateos R. Enfermedad hepática inducida por alcohol. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:182-190. [DOI: 10.1016/j.med.2020.02.002] [Reference Citation Analysis]
244 Tubío AF, Sánchez-aldehuelo R, García AG, Martín-mateos R. Protocolo diagnóstico y tratamiento de la hepatitis alcohólica. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:220-224. [DOI: 10.1016/j.med.2020.02.006] [Reference Citation Analysis]
245 Fabrellas N, Carol M, Palacio E, Aban M, Lanzillotti T, Nicolao G, Chiappa MT, Esnault V, Graf-Dirmeier S, Helder J, Gossard A, Lopez M, Cervera M, Dols LL; LiverHope Consortium Investigators. Nursing Care of Patients With Cirrhosis: The LiverHope Nursing Project. Hepatology 2020;71:1106-16. [PMID: 31944340 DOI: 10.1002/hep.31117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
246 Deltenre P, Trépo E, Fujiwara N, Goossens N, Marot A, Dubois M, Spahr L, Henrion J, Moreno C, Hoshida Y. Gene signature-MELD score and alcohol relapse determine long-term prognosis of patients with severe alcoholic hepatitis. Liver Int 2020;40:565-70. [PMID: 31568650 DOI: 10.1111/liv.14265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
247 Dalekos GN, Gatselis NK, Zachou K, Koukoulis GK. NAFLD and autoimmune hepatitis: Do not judge a book by its cover. Eur J Intern Med 2020;75:1-9. [PMID: 32051092 DOI: 10.1016/j.ejim.2020.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
248 Huang S, Zhou C, Zeng T, Li Y, Lai Y, Mo C, Chen Y, Huang S, Lv Z, Gao L. P-Hydroxyacetophenone Ameliorates Alcohol-Induced Steatosis and Oxidative Stress via the NF-κB Signaling Pathway in Zebrafish and Hepatocytes. Front Pharmacol 2019;10:1594. [PMID: 32047433 DOI: 10.3389/fphar.2019.01594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
249 O’gurek DT. Diseases of the Liver. Family Medicine 2020. [DOI: 10.1007/978-1-4939-0779-3_97-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
250 Lucey MR, Im GY, Mellinger JL, Szabo G, Crabb DW. Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease. Liver Transpl 2020;26:14-6. [PMID: 31299131 DOI: 10.1002/lt.25600] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
251 Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im G, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transpl 2020;26:127-40. [PMID: 31743578 DOI: 10.1002/lt.25681] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 18.7] [Reference Citation Analysis]
252 Williams JA, Ding WX. Role of autophagy in alcohol and drug-induced liver injury. Food Chem Toxicol 2020;136:111075. [PMID: 31877367 DOI: 10.1016/j.fct.2019.111075] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
253 Miller ED, Abu-sbeih H, Chalasani NP. Drug-Induced Liver Injury in Older Adults. In: Pitchumoni CS, Dharmarajan T, editors. Geriatric Gastroenterology. Cham: Springer International Publishing; 2019. pp. 1-16. [DOI: 10.1007/978-3-319-90761-1_53-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
254 Daniel KE, Lucey MR. Editorial: moderate alcoholic hepatitis-hiding in plain sight. Aliment Pharmacol Ther 2019;50:608-9. [PMID: 31414539 DOI: 10.1111/apt.15436] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]